Bone up on proton pump inhibitors and fracture risk

Nursing

Volumn 37, Issue 10, 2007, Pages 60-61

  Gendreau Webb, Rosalyn ^a  

^a Maine Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG; PROTON PUMP INHIBITOR;

ANAMNESIS; ARTICLE; CHEMICALLY INDUCED DISORDER; FRACTURE; GASTROESOPHAGEAL REFLUX; HUMAN; LIFESTYLE; NURSE ATTITUDE; NURSING ASSESSMENT; PATIENT EDUCATION; RISK FACTOR; TIME;

DRUGS, NON-PRESCRIPTION; FRACTURES, BONE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; LIFE STYLE; MEDICAL HISTORY TAKING; NURSE'S ROLE; NURSING ASSESSMENT; PATIENT EDUCATION AS TOPIC; PROTON PUMP INHIBITORS; RISK FACTORS; TIME FACTORS;

EID: 34848819730     PISSN: 03604039     EISSN: 15388689     Source Type: Journal    
DOI: 10.1097/01.NURSE.0000292018.70046.91     Document Type: Short Survey

References (6)

1. Yang YX, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 296(24):2947-2953, December 27, 2006.
2. Vestergaard P, et al. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcified Tissue International. 79(2):76-83, August 2006.
3. Bacak BS, et al. What is the best way to manage GERD symptoms in the elderly? The Journal of Family Practice. 55(3):251-254, March 2006.
4. Hirota K, et al. Regular use of H2 blockers reduces the efficacy of roxatidine to control gastric pH and volume. Canadian Journal of Anaesthesia. 52(2):166-171, February 2005.
5. American College of Gastroenterology. Patient information page. http://www.acg.gi.org/patients. Accessed June 12, 2007.
6. Welage LS. Pharmacologic properties of proton pump inhibitors. Pharmacotherapy. 23(10 Part 2):74S-80S, October 2003.